Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on July 15, 2026

Jul. 15, 2026

Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors

Indeterminate GlobeNewswire

Jul. 15, 2026

Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells

Indeterminate GlobeNewswire

Jul. 15, 2026

NOMAD Power Solutions Strengthens Subsidiary Executive Leadership

Indeterminate GlobeNewswire

Jul. 15, 2026

Biogen Appoints Michael J. Parini as Chief Legal Officer

Indeterminate GlobeNewswire

Jul. 15, 2026

BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027

Indeterminate GlobeNewswire

Jul. 15, 2026

MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients

Indeterminate GlobeNewswire

Jul. 15, 2026

Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn

Indeterminate GlobeNewswire

Jul. 15, 2026

Valitor to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire

Jul. 15, 2026

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

Indeterminate GlobeNewswire

Jul. 15, 2026

Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform

Indeterminate GlobeNewswire

Jul. 15, 2026

aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Indeterminate GlobeNewswire

Jul. 15, 2026

VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million

Indeterminate GlobeNewswire

Jul. 15, 2026

Cardiff Oncology Announces $10 Million Registered Direct Offering

Indeterminate GlobeNewswire

Jul. 15, 2026

Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio

Indeterminate GlobeNewswire

Jul. 15, 2026

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Indeterminate GlobeNewswire

Jul. 15, 2026

Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

Indeterminate GlobeNewswire